Activated human mast cells induce LOX-1-specific scavenger receptor expression in human monocyte-derived macrophages

PLoS One. 2014 Sep 24;9(9):e108352. doi: 10.1371/journal.pone.0108352. eCollection 2014.

Abstract

Objective: Activated mast cells in atherosclerotic lesions degranulate and release bioactive compounds capable of regulating atherogenesis. Here we examined the ability of activated human primary mast cells to regulate the expression of the major scavenger receptors in cultured human primary monocyte-derived macrophages (HMDMs).

Results: Components released by immunologically activated human primary mast cells induced a transient expression of lectin-like oxidized LDL receptor (LOX-1) mRNA in HMDMs, while the expression of two other scavenger receptors, MSR1 and CD36, remained unaffected. The LOX-1-inducing secretory components were identified as histamine, tumor necrosis factor alpha (TNF-α), and transforming growth factor beta (TGF-β1), which exhibited a synergistic effect on LOX-1 mRNA expression. Histamine induced a transient expression of LOX-1 protein. Mast cell -induced increase in LOX-1 expression was not associated with increased uptake of oxidized LDL by the macrophages.

Conclusions: Mast cell-derived histamine, TNF-α, and TGF-β1 act in concert to induce a transient increase in LOX-1 expression in human primary monocyte-derived macrophages. The LOX-1-inducing activity potentially endows mast cells a hitherto unrecognized role in the regulation of innate immune reactions in atherogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD36 Antigens / genetics
  • Cells, Cultured
  • Histamine / metabolism
  • Histamine / pharmacology
  • Humans
  • Macrophages / cytology
  • Macrophages / drug effects*
  • Macrophages / metabolism
  • Mast Cells / cytology
  • Mast Cells / immunology*
  • Scavenger Receptors, Class A / genetics
  • Scavenger Receptors, Class E / genetics*
  • Scavenger Receptors, Class E / metabolism*
  • Transforming Growth Factor beta1 / metabolism
  • Transforming Growth Factor beta1 / pharmacology
  • Tumor Necrosis Factor-alpha / metabolism
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • CD36 Antigens
  • MSR1 protein, human
  • OLR1 protein, human
  • Scavenger Receptors, Class A
  • Scavenger Receptors, Class E
  • TGFB1 protein, human
  • Transforming Growth Factor beta1
  • Tumor Necrosis Factor-alpha
  • Histamine

Grants and funding

Wihuri Research Institute is maintained by the Jenny and Antti Wihuri Foundation. This study was also supported by a grant from the Academy of Finland to K.Ö. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.